Sun Yang, Liu Shasha, Chen Chen, Yang Songwei, Pei Gang, Lin Meiyu, Wang Ting, Long Junpeng, Yan Qian, Yao Jiao, Lin Yuting, Yi Fan, Meng Lei, Tan Yong, Ai Qidi, Chen Naihong, Yang Yantao
Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, College of Pharmacy, Hunan University of Chinese Medicine, Changsha, P. R. China.
Department of Pharmacy, Changsha Hospital for Matemal & Child Health Care, Changsha, P. R. China.
Cell Death Discov. 2023 Feb 25;9(1):78. doi: 10.1038/s41420-023-01373-6.
Pulmonary hypertension (PH) was a cardiovascular disease with high morbidity and mortality. PH was a chronic disease with complicated pathogenesis and uncontrollable factors. PH was divided into five groups according to its pathogenesis and clinical manifestations. Although the treatment and diagnosis of PH has made great progress in the past ten years. However, the diagnosis and prognosis of the PAH had a great contrast, which was not conducive to the diagnosis and treatment of PH. If not treated properly, it will lead to right ventricular failure or even death. Therefore, it was necessary to explore the pathogenesis of PH. The problem we urgently need to solve was to find and develop drugs for the treatment of PH. We reviewed the PH articles in the past 10 years or so as well as systematically summarized the recent advance. We summarized the latest research on the key regulatory factors (pyroptosis, apoptosis, necroptosis, ferroptosis, and endoplasmic reticulum stress) involved in PH. To provide theoretical basis and basis for finding new therapeutic targets and research directions of PH.
肺动脉高压(PH)是一种发病率和死亡率都很高的心血管疾病。PH是一种发病机制复杂且存在不可控因素的慢性疾病。根据其发病机制和临床表现,PH可分为五组。尽管在过去十年中,PH的治疗和诊断取得了很大进展。然而,PAH的诊断和预后存在很大差异,这不利于PH的诊断和治疗。如果治疗不当,将导致右心衰竭甚至死亡。因此,有必要探索PH的发病机制。我们迫切需要解决的问题是找到并开发治疗PH的药物。我们回顾了过去10年左右关于PH的文章,并系统总结了最新进展。我们总结了PH中涉及的关键调节因子(细胞焦亡、凋亡、坏死性凋亡、铁死亡和内质网应激)的最新研究。为寻找PH新的治疗靶点和研究方向提供理论依据和基础。